EvoNexus Company, Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery
EvoNexus Company, Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery “One year before a world-wide pandemic occurred, Carlsmed applied to enter EvoNexus. Their plan was to […]